Expedited Mapping of the Ligandable Proteome Using Fully Functionalized Enantiomeric Probe Pairs

27 February 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A fundamental challenge in chemical biology and medicine is to understand and expand the fraction of the human proteome that can be targeted by small molecules. We recently described a strategy that integrates fragment-based ligand discovery with chemical proteomics to furnish global portraits of reversible small molecule-protein interactions in human cells.
Excavating clear structure-activity relationships from these “ligandability” maps, however, was confounded by the distinct physicochemical properties and corresponding overall protein-binding potential of individual fragments. Here, we describe a compelling solution to this problem by introducing a next-generation set of fully functionalized fragments (FFFs) differing only in absolute stereochemistry. Using these enantiomeric probe pairs, or “enantioprobes”, we identify numerous stereoselective protein-fragment interactions in cells and show that these interactions occur at functional sites on proteins from diverse classes. Our findings thus indicate that incorporating chirality into FFF libraries provides a robust and streamlined method to discover ligandable proteins in cells.

Keywords

chemical proteomics
enantiomers
fragments
ligands
proteins

Supplementary materials

Title
Description
Actions
Title
Wang etal 2019 SupplementaryTable3
Description
Actions
Title
Wang etal 2019 SupplementaryTable2
Description
Actions
Title
Wang etal 2019 SupplementaryTable1
Description
Actions
Title
Wang etal 2019 SupplementaryInformation Final
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.